Browsing items tagged “HEOR | EVERSANA”

EVERSANA to present at the Virtual ISPOR 2020

Analyze, Deliver, Measure and Communicate Value at Every Stage of the Product Lifecycle. Join our experts LIVE during one of the 4 presentations to get a deeper understanding of key issues impacting our value-driven healthcare environment. Request a time to meet.     PANEL: ARE EXISTING REGULATORY EVIDENCE STANDARDS ADEQUATE FOR INFORMING DECISIONS ON MEDICAL […]

ICER Indefinitely Postpones Public Meetings for Sickle Cell Disease and Cystic Fibrosis; Expands Other Assessment Timelines Up to Three Months

BOSTON, March 18, 2020 – The Institute for Clinical and Economic Review (ICER) today announced several changes to its timelines for upcoming assessments. ICER’s review process involves significant engagement across a variety of external stakeholders — health care providers, life sciences companies, health insurers, and patient advocacy groups — the same types of organizations that […]

EVERSANA™ announces an agreement to acquire Cornerstone Research Group; adds global HEOR capabilities to integrated commercial services platform

CHICAGO  – October 30, 2019  – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Headquartered in Burlington, Ontario with an additional location in Sydney, Nova Scotia, Cornerstone Research Group is the leader in Health Economics and Outcomes Research (HEOR) […]